Claudia Chen

Claudia is an accomplished venture capital professional with expertise in healthcare early-stage investing. Throughout her career, she has managed high-impact investments in biotechnology, medtech, and digital health, successfully leading due diligence and portfolio management for pioneering startups. Her dedication to identifying and supporting disruptive companies addressing critical healthcare challenges has resulted in transformative outcomes for both founders and investors.

As a Senior Associate at Forepont Capital Partners, Claudia has been pivotal in expanding the firm’s portfolio and strengthening its presence in the early-stage investment landscape. She leads the full investment lifecycle, including sourcing opportunities, conducting in-depth financial modeling and due diligence, and providing ongoing strategic guidance to portfolio companies. Claudia’s venture capital expertise is built on a strong foundation in finance through roles at Morgan Stanley Wealth Management and SinoPac Holdings, where she gained experience in portfolio management, investor relations, and capital-raising initiatives. She holds a Bachelor’s degree in Finance, Computing, and Data Science from New York University.

Recognized for her analytical expertise and collaborative leadership, Claudia is dedicated to driving long-term value by fostering innovation that aligns with social and environmental impact goals. Her work continues to generate meaningful outcomes for startups, investors, and the broader community.

Expertise

Venture capital, early-stage investing, portfolio management, and startup strategic support

Location

New York, NY

Roles

Senior Investment Associate, Strategy and Business Development, Investor Relations Analyst

Sectors

Biotechnology, medtech, digital health, and emerging technologies

Traits

Analytical, collaborative, innovation-focused, results-driven